Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Carnival Corp (CCL) vs Johnson & Johnson (JNJ) Price & Performance

Carnival CorpTrade
Johnson & JohnsonTrade

Price performance (Past 24H)

Key statistics

Carnival Corp vs Johnson & Johnson — how do they compare? Carnival Corp trades at $26.6 (market cap $36.30B), while Johnson & Johnson trades at $247.83 (market cap $611.07B). The key difference: Johnson & Johnson is far larger — about 16.8× Carnival Corp's market cap, and Johnson & Johnson pays the higher dividend (2.11%). Which is the better fit depends on your goals.

CCLJNJ
Market Cap
$36.30B$611.07B
Sector
Consumer CyclicalHealth
52-Week High
$33.99$267.24
52-Week Low
$23.89$155.17
Enterprise Value
$60.22B$644.01B
Dividend Yield
1.7%2.11%
Volume
6,156,228

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Carnival Corp

Carnival Corporation (CCL) trades at $26.61, down 0.82% on the day, amid a bearish technical signal. The company demonstrates strong fundamental improvement with revenue growth to $26.62 billion in 2025 and net income of $2.76 billion, supported by three consecutive quarterly EPS beats. Positive analyst sentiment is evident with a $35.00 consensus price target and 59.57% buy ratings, while recent news highlights fleet expansion and strong bookings.

The outlook remains positive due to robust demand and cost controls, but risks include geopolitical tensions impacting fuel costs and softer European demand. The stock's current valuation metrics, such as a P/E of 11.99, suggest potential upside if execution continues, though investors must weigh debt levels and macroeconomic headwinds.

Johnson & Johnson

Johnson & Johnson (JNJ) trades at $257.77, up 0.31% with a bullish technical signal and strong institutional support. The stock shows robust fundamentals with 2025 revenue of $94.19B, net income margin of 21.83%, and consistent earnings beats. Recent dividend declaration of $1.34 and positive analyst coverage with 52.5% buy ratings reinforce confidence. The current price sits near pivot point resistance at $258, with technical indicators showing bullish momentum from moving averages.

JNJ presents a compelling long-term investment with stable cash flows, strong profitability metrics, and defensive healthcare positioning. Upside potential exists toward the $281 consensus price target, though risks include rising debt-to-asset ratio (24.06% in 2025) and patent expiration headwinds. The stock's 60+ year dividend growth history provides income stability amid market volatility.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Carnival Corp

Carnival is the largest global cruise company, with 91 ships in its fleet in October 2022, with eight of its nine brands set to be fully redeployed by the end of 2022. Its portfolio of brands includes Carnival Cruise Lines, Holland America, Princess Cruises, and Seabourn in North America.

Read more on CCL

About Johnson & Johnson

Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.

Read more on JNJ